Major breakthrough appetite suppressing drug cuts obesity by 20 percent
Hailed as a “gamechanger” medication for tackling obesity, a large-scale double-blind international trial study of almost 2,000 people in 16 countries, found the generic drug named Semaglutide (Ozempic is the brand name), instrumental in achieving a significant amount of weight loss among the participants. Adults on semaglutide lost an average of 14.9% (33.7 lbs) of… Read more